Status
Conditions
Treatments
About
The current study aims to assess the HemoControl prescription in On-Line Hemodiafiltration treatment.
Full description
Hemodiafiltration (HDF) is a dialysis technique that allows the removal of high molecular weight toxic solutes exploiting the convective transport through the dialyzer membrane: at the same time, the HDF has a positive impact on the systemic hemodynamic, ameliorating in this way the tolerance of the treatment. Unfortunately, also the HDF therapy can be not well tolerated, introducing in the patients serious hypovolemia during the removal of the body water accumulated in the interdialytic period.
The HemoControl system, automatically controlling the relative blood volume change of the patient, avoids the onset of the hypovolemia. Today the HemoControl system can be used only during conventional hemodialysis treatments; the objective of this study is to combine the advantages of the intradialytic hemodynamic stabilization achievable by means of HemoControl with the inherent advantages, both of depurative and cardiovascular kind, typical of the Hemodiafiltration technique.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
A subject must meet ALL of the following inclusion criteria in order to participate in this study:
Exclusion criteria
A subject shall NOT participate in the study if he/she meets ANY of the following criteria:
Primary purpose
Allocation
Interventional model
Masking
7 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal